Biomimetic nanosystems inspired by extracellular vesicles are being studied as a promising way to balance immune responses and treat sepsis-induced acute lung injury.
Read the full answer →
Vaping-associated acute lung injury is often linked to products containing cannabinoids and frequently presents with patterns like diffuse alveolar damage or organizing pneumonia.
Read the full answer →
Recombinant human plasma gelsolin (rhu-pGSN) was found to be safe and well-tolerated in a Phase 1 trial involving healthy volunteers.
Read the full answer →
Research suggests that microRNAs (miRNAs) can regulate neutrophil behavior and may offer a promising way to treat acute lung injury, though most evidence currently comes from preclinical studies.
Read the full answer →
Extracellular vesicles show potential as both a contributor and a therapeutic target in sepsis-related acute lung injury, but clinical use is still experimental.
Read the full answer →